INARMERA

INTEGRATING ARMENIA INTO ERA

 Partecipanti

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Integration of the South Caucasus countries into ERA is one of the priorities of EU’s European Neighbourhood Policy. This is the objective of ERAWIDE initiative aimed at reinforcing the cooperation capacity of a prominent R&D centre in these countries by providing the possibilities to improve its research activities in the areas of thematic priorities of FP7. The government of the Republic of Armenia recommended as such a centre the Center of Medical Genetics and Primary Health Care (CMG) due to its high reputation, broad international contacts, participation in FP7, and the importance of the top-level research in Medical Genetics for general population. To reach this objective, the INARMERA project consortium consisting of CMG, the Institute of Cancer Biology of the Danish Cancer Society, and the European Centre for Knowledge and Technology Transfer (Belgium) will carry out research assessment of CMG, will organise training in FP7 for CMG scientists and their research training in Medical Genetics. For networking and dissemination purposes workshops and summer schools will be organised in Armenia while Armenian scientists will attend events in Europe. Meantime from the start of INARMERA four Pilot Trial Projects in Medical Genetics will be organised between CMG scientists and their colleagues in Europe, but also in Georgia, highlighting the regional aspect of INARMERA. The Pilot Trials will help Participants to identify bottlenecks of cooperation and propose improvements. The Strategy Experts Group will develop strategy of CMG aiming at establishment of CMG as a visible centre of Medical Genetics studies in Caucasus, and turning it into a reliable partner for European institutions in Framework Programmes. Project results and achievements will be analysed and recommendations will be drawn to the authorities on strengthening EU-Armenia R&D cooperation leading to the successful start of integration of Armenia into ERA.'

Introduzione (Teaser)

An EU-funded project boosted European Commission efforts to enhance international cooperation in science and technology (S&T). INARMERA boosted EU cooperation with Armenia through support activities aimed at strengthening one of its research centres.

Descrizione progetto (Article)

One of the priorities of the EU's European Neighbourhood Policy (ENP) is the integration of South Caucasus countries into the European Research Area (ERA). The goal is to reinforce the cooperation capacity of a selected research and development centre in these countries through enhanced research activities in areas of thematic priorities of the Seventh Framework Programme (FP7). The Armenian government recommended the Center of Medical Genetics and Primary Health Care (CMG).

The 'Integrating Armenia into ERA' (INARMERA) project aimed at enhancing cooperation at different levels, widening the scope of cooperation involving more EU countries and research centres, and covering more topics of mutual interest.

Armenian participation in FP7 project proposals was increased and links strengthened between policymakers in Armenia and the EU in S&T. The project team organised training in FP7 for CMG scientists, and offered opportunities for their research training in medical genetics.

A professional strategy expert group assessed the usefulness and impact of all CMG programmes and activities. The evaluation drew on results such as research, partnerships and public engagement, translation and use of knowledge, as well as organisational excellence.

Various key efforts were directed at reinforcing cooperation between the CMG and European research centres in areas of mutual research. To this end, a networking and dissemination plan was developed in line with the project objectives.

Promotion and information materials were widely circulated to Armenian and EU stakeholders and organisations. In addition, cooperation and synergy-building activities with national and EU projects were carried out.

INARMERA drove new medical genetics methods to the forefront of the Armenian scientific community and greatly increased its visibility among the general public. In enabling the CMG to increase its scale and regional coverage, the project improved its ability to respond to the socioeconomic needs of Armenia and the wider region.